Login / Signup

Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.

Stephen CaldwellRobert J WongJeremy FraysseSanatan ShreaySuying LiStephen HarrisonStuart C Gordon
Published in: Alimentary pharmacology & therapeutics (2020)
The present report (a) demonstrates that NAFLD is grossly underdiagnosed in real-world clinical settings and (b) provides new evidence on the progression rates of NAFLD and risk factors of mortality across the spectrum of severity of NAFLD and cirrhosis.
Keyphrases
  • risk factors
  • cardiovascular events
  • electronic health record
  • type diabetes
  • healthcare
  • big data
  • coronary artery disease
  • machine learning
  • deep learning
  • artificial intelligence
  • health insurance